Mobilization of Philadelphia chromosome (Ph) negative blood progenitors was attempted in 23 newly diagnosed chronic myeloid leukaemia (CML) patients using a regimen of cyclophosphamide (CY) 5 g/m² and rHUG-CSF 150 μg/m² daily. This regimen was well tolerated with no major adverse events reported. More than 2 × 10⁶/kg CD34⁺ cells were collected in 21 patients (91%). Predominantly Ph-negative mobilization (0–25% Ph-positive) was seen in 30% of cases overall and was confined to patients with a Sokal prognostic score < 1 (7/11 with Sokal score <1; 0/12 with Sokal score ≥1). Within the low Sokal index group, a low WBC count pre-mobilization and a low WBC nadir both correlated strongly with Ph-negative mobilization (P =0.006 and 0.02 respectively...
The aims of this study were (1) to evaluate the effect of intermediate (cyclophosphamide alone) or i...
Two patients with Philadelphia chromosome-positive (Ph +) chronic myeloid leukaemia (CML) relapsed 1...
PURPOSE: To determine, in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous le...
Imatinib mesylate (IM, STI 571, Glivec(R)) can induce a high rate of complete cytogenetic response (...
We carried out studies to quantify Ph-negative progenitors both in steady state and during regenerat...
OBJECTIVE: In many patients with chronic myeloid leukemia (CML), a residual population of primitive ...
BACKGROUND: Clonal cytogenetic abnormalities (CCA) were detected in Philadelphia chromosome (Ph)-neg...
some-negative progenitors is now possible in many Ph'-positive chronic myelogenous leukemia (CM...
INTRODUCTION: Normal immature hematopoietic progenitors are relatively well preserved in most patien...
The aims of this study were (1) to evaluate the effect of intermediate (cyclophosphamide alone) or i...
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder as a result of neoplastic tra...
INTRODUCTION: Normal immature hematopoietic progenitors are relatively well preserved in most patien...
markdownabstractAbstract Between 1985 and 1989, many cases of Philadelphia (Ph) chromosome negati...
We collected peripheral blood stem cells (PBSC) in 19 early chronic phase CML patients following eac...
Chronic myeloid leukemia (CML) is a disorder of blood stem cells in bone marrow, which leads to a ra...
The aims of this study were (1) to evaluate the effect of intermediate (cyclophosphamide alone) or i...
Two patients with Philadelphia chromosome-positive (Ph +) chronic myeloid leukaemia (CML) relapsed 1...
PURPOSE: To determine, in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous le...
Imatinib mesylate (IM, STI 571, Glivec(R)) can induce a high rate of complete cytogenetic response (...
We carried out studies to quantify Ph-negative progenitors both in steady state and during regenerat...
OBJECTIVE: In many patients with chronic myeloid leukemia (CML), a residual population of primitive ...
BACKGROUND: Clonal cytogenetic abnormalities (CCA) were detected in Philadelphia chromosome (Ph)-neg...
some-negative progenitors is now possible in many Ph'-positive chronic myelogenous leukemia (CM...
INTRODUCTION: Normal immature hematopoietic progenitors are relatively well preserved in most patien...
The aims of this study were (1) to evaluate the effect of intermediate (cyclophosphamide alone) or i...
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder as a result of neoplastic tra...
INTRODUCTION: Normal immature hematopoietic progenitors are relatively well preserved in most patien...
markdownabstractAbstract Between 1985 and 1989, many cases of Philadelphia (Ph) chromosome negati...
We collected peripheral blood stem cells (PBSC) in 19 early chronic phase CML patients following eac...
Chronic myeloid leukemia (CML) is a disorder of blood stem cells in bone marrow, which leads to a ra...
The aims of this study were (1) to evaluate the effect of intermediate (cyclophosphamide alone) or i...
Two patients with Philadelphia chromosome-positive (Ph +) chronic myeloid leukaemia (CML) relapsed 1...
PURPOSE: To determine, in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous le...